Clinical Trial Update: A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SHR-1701 with or without chemotherapy in stage III non-small cell lung cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SHR-1701

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: UNKNOWN